Generalized immunosuppression-associated type Kaposi's sarcoma in a patient with severe refractory bullous pemphigoid
Journal
Dermatologica Sinica
Journal Volume
26
Journal Issue
2
Pages
85-92
Date Issued
2008
Author(s)
Abstract
The progression of immunosuppression-associated type Kaposi's sarcoma (KS) is thought to be related to the immunocompromised status. We herein describe a case, who had a quiescent initial lesion of KS developed in the sixth month after receiving immunosuppressive therapy for treating the refractory bullous pemphigoid. The activity of KS increased abruptly during a period of lymphocytopenia. Subsequent analysis showed CD4+ lymphocytopenia and negative anti-HIV antibody. While the dosage of corticosteroid was tapered, intralesional interferon-α2b injection was given as adjuvant therapy. The injected lesions gradually became less painful with obvious necrotic appearance. Cryotherapy and fractional radiotherapy were administered additionally and on the sixth-month of follow-up, it was observed that the majority of KS lesions had regressed.
Subjects
Bullous pemphigoid; Interferone-α2b; Kaposi's sarcoma; Lymphocytopenia
SDGs
Other Subjects
amoxicillin plus clavulanic acid; azithromycin; cefepime; clobetasol propionate; corticosteroid; fluconazole; Human immunodeficiency virus antibody; immunoglobulin; interferon alpha2b; lamivudine; methylprednisolone; nystatin; piperacillin plus tazobactam; prednisolone; adult; article; bullous pemphigoid; cancer adjuvant therapy; cancer radiotherapy; case report; CD4+ T lymphocyte; cryotherapy; drug dose increase; drug dose reduction; drug substitution; drug withdrawal; electron microscopy; follow up; hepatitis B; hospitalization; human; human tissue; immunoblotting; immunosuppressive treatment; injection; Kaposi sarcoma; liver function test; lymphocytopenia; male; serology; skin biopsy
Type
journal article